Vivek Ramaswamy Quotes

I keep encouraging the pharmaceutical companies to put more money into R&D.

Cadila, India's sixth-largest drugmaker by sales, spent $250 million developing Lipaglyn, a new chemical entity or new discovery, and aims to spend another $150 million to $200 million to launch the drug outside India.

To start with, pharma was an industry based on innovation, drug discovery.

I've heard drug experts say they believe if penicillin were discovered today, the FDA wouldn't license it.

There's always going to be the need for new medications, better medications.

Would-be drug companies must either produce medicines that stand up to federal scrutiny, demonstrate that their data has value to other companies, or go out of business.

In general, drug companies are reasonably good at developing new treatments, and there's also a lot of good in the industry.

If you go to the FDA with a drug that's only meant to treat 50 people, and it's a 95 percent cure rate, you'll get your drug approved.

The United States has an active pharmaceutical industry that has brought huge benefits to the U.S. public. Most Americans, who benefit from these advances, have little understanding of how difficult it is to create an important new medical therapy and make it available to improve public health.

We should look for ways to expedite generic drug approvals, particularly for products that have a long history of being safe and effective.

There is probably a promising drug candidate that has already been discovered for the treatment of Down syndrome that is sitting on the shelf of some drug company.

On the third stage is used for medicine, it is not known to the public.

Now, what tends to happen is that the stories get hyped. And the medicines are not quite as revolutionary and as dramatic as they seem to be. But, certainly, various phases of this problem are being attacked by the pharmaceutical companies.

I'd like to focus on my life on creating new medicines for people who are suffering from rare disease.

Analytical pharmacology has got an important and exciting future.

Drug discovery is terribly expensive, just to find out how one drug could or could not work and all its side effects.

I want to make a drug. I want the science to be more than imaginary, where I think, 'We're learning these fundamental principles, blah, blah, blah, blah, blah.' I think we are doing that, but I want to do something really practical. I want to actually, in my lifetime, help people.

All I ever promised was that I was sure I could develop a new pharmacological agent which might answer a physiological question. Any utility would be implicit in that answer.

Efforts to approach zero risk through exhaustive pre-release testing are extremely expensive and time-consuming. New drugs are delayed in reaching those who need them, and marginal drugs may not be developed at all.

If we can actually decrease the failure rate from nine out of 10 drugs failing in clinical trials and instead have seven out of 10 instead failing, that is a major victory for drug discovery and for people having better therapy.

When you work in the pharmaceutical industry you realize that there's a lot out of people's control, and there's ways that people can be helped.

I really was inspired by the possibility of more directly being involved in the development of drugs myself.

Fundamental discoveries can and should be made in industry or academies, but to carry that knowledge forward and to develop a new drug to the market has to depend on the resources of industry.

I agree, the world would be a better place if doctors were less enthusiastic about adopting very new drugs.

I think FDA's concerns are patient-safety.